Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

99.83
+1.491.52%
Post-market: 99.930.1000+0.10%19:59 EDT
Volume:495.62K
Turnover:49.20M
Market Cap:6.48B
PE:-7.09
High:101.00
Open:98.95
Low:97.66
Close:98.34
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:1.12
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-621.97
PE(LYR):-212.40

Loading ...

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Fate Therapeutics (FATE) and Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
May 27

H.C. Wainwright Reaffirms Their Buy Rating on Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
May 22

Mirum presents late-breaking Phase 2b VISTAS volixibat data in PSC pruritus at EASL 2026

Reuters
·
May 21

U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv

Reuters
·
May 20

Mirum Pharmaceuticals Initiated at Outperform by Wolfe Research

Dow Jones
·
May 19

Mirum Pharmaceuticals initiated with an Outperform at Wolfe Research

TIPRANKS
·
May 19

Mirum director Saira Ramasastry disposes of common shares worth $218,940

Reuters
·
May 19

Mirum plans USD 600 million convertible senior notes offering due 2032

Reuters
·
May 19

What Mirum Pharmaceuticals (MIRM)'s Volixibat PSC Trial Win and $600M Notes Deal Means For Shareholders

Simply Wall St.
·
May 18

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 15

Stock Track | Mirum Pharmaceuticals Soars 5.26% Intraday on Favorable Debt Offering and Positive Drug Trial Results

Stock Track
·
May 13

BRIEF-Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering

Reuters
·
May 13

Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals announces $600M convertible senior notes offering

TIPRANKS
·
May 13

Mirum Pharmaceuticals Plans Offering of Senior Notes due 2032

MT Newswires Live
·
May 13

BUZZ-Mirum Pharma drops on announcing $600 mln convertible debt deal

Reuters
·
May 13

Mirum plans USD 600 million convertible senior notes offering due 2032

Reuters
·
May 13

Mirum Pharmaceuticals Inc - Initial Purchasers May Buy up to $90 Mln Additional Notes

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals Inc - Notes to Mature on June 1, 2032

THOMSON REUTERS
·
May 13